Stiff-Person Syndrome: Clinical Trials

20 trials for Stiff-Person Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 not yet recruiting, 3 recruiting, 2 unknown. 7 Phase 2, 5 Phase 1, 3 Phase 3, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 27Completed 2, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 15Not yet recruiting 2, Completed 1, Enrolling by invitation 1, Terminated 1
Phase 33Not yet recruiting 1, Recruiting 1, Withdrawn 1
Early Phase 11Withdrawn 1
Not applicable1Completed 1

Follow Stiff-Person Syndrome: new trials by email Literature Review of Stiff-Person Syndrome trials Research Report on Stiff-Person Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome
Kedrion IVIg 10%, Human Albumin - Stiff Person Syndrome
Phase 3Not yet recruitingKedrion S.p.A.382026-11-012026-10-22
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease
CTX112 - Progressive Multiple Sclerosis (PMS), Neuromyelitis Optica
Phase 1 / Phase 2Not yet recruitingCRISPR Therapeutics2202026-11-012026-10-22
VYVGART (Hytrulo) in Patients With Stiff Person Syndrome (SPS)
VYVGART Hytrulo, Hytrulo-placebo (consisting of Hyaluronidase) - Stiff Person Syndrome
Phase 2 / Phase 3RecruitingThomas Jefferson University262026-09-302026-10-06
Extracorporeal Photopheresis (ECP) in the Treatment of Stiff Person Syndrome (OPTION Study)
Extracorporeal photopheresis (ECP) - Stiff Person Syndrome
Early Phase 1WithdrawnYandy Marx Castillo Aleman2026-08-012026-08-06
A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy
CD20/BCMA-directed CAR-T cells - Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorders (NMOSD)
Phase 1Not yet recruitingHuashan Hospital152026-02-012026-01-15
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
KYV-101 - Refractory Lupus Nephritis, Myasthaenia Gravis
RecruitingKyverna Therapeutics702025-11-242026-02-11
Efgartigimod for Stiff Person Syndrome (ESPS)
Efgartigimod - Stiff-Person Syndrome
Phase 2Not yet recruitingUniversity of South Florida102025-04-012025-04-11
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
ADI-001, Fludarabine, Cyclophosphamide - Lupus Nephritis, Autoimmune Diseases
Phase 1Enrolling by invitationAdicet Therapeutics1802024-11-102026-03-19
Evaluating Spinal Cord Stimulation for Stiff Person Syndrome
SCS trial lead - Stiff-Person Syndrome
Not applicableCompletedWake Forest University Health Sciences22024-11-012026-08-31
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
Standard lymphodepletion regimen - Stiff-Person Syndrome, SPS
Phase 2CompletedKyverna Therapeutics272024-09-252026-07-24
Biomarkers in Autoimmune Disease of Nervous System
biomaker levels - Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder
RecruitingTongji Hospital500002024-07-312026-07-29
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
HLA Analysis in Autoimmune Encephalitis and Related Disorders
Autoimmune Encephalitis, Imbic Encephalitis
UnknownHospices Civils de Lyon1602019-10-012019-09-27
Efficacy and Mechanism of Action of SCIg in Patients With Stiff Person Syndrome (SPS)
HyQvia - Stiff-Person Syndrome
UnknownThomas Jefferson University222019-06-012019-05-14
Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome
Intravenous Immunoglobulins, Human, Placebos - Stiff-Person Syndrome
Phase 3WithdrawnMayo Clinic2018-12-072019-06-13
Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna - Stiff-Person Syndrome
Phase 1 / Phase 2TerminatedNorthwestern University232014-10-012021-01-27
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Anti-Thymocyte Globulin, Autologous Hematopoietic Stem Cell Transplantation, Carmustine - Autoimmune Disease, Neurologic Autoimmune Disease
Phase 2Active not recruitingFred Hutchinson Cancer Center532008-06-012026-02-27
Rituximab to Treat Stiff Person Syndrome
Rituximab, rituximab or placebo - Stiff Person Syndrome
Phase 2CompletedNational Institute of Neurological Disorders and Stroke (NINDS)242004-09-012011-08-31
Cause, Development, and Progression of Stiff-Person Syndrome
Stiff-Person Syndrome
CompletedNational Institute of Neurological Disorders and Stroke (NINDS)402002-02-112017-07-02
Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
IVIg - Muscle Rigidity, Spasm
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)201996-04-012006-07-14

Narrower conditions

Autoimmune Diseases (5)  ·  Autoimmune Diseases of the Nervous System (5)  ·  Neuromyelitis Optica (4)  ·  Multiple Sclerosis (3)  ·  Lupus Nephritis (2)  ·  Myasthenia Gravis (2)  ·  Myositis (2)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (2)  ·  Scleroderma, Systemic (2)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)  ·  Adrenal Hyperplasia, Congenital (1)

Broader conditions

Central Nervous System Diseases (20)  ·  Immune System Diseases (20)  ·  Neuromuscular Diseases (20)  ·  Spinal Cord Diseases (20)  ·  Nervous System Diseases (19)  ·  Autoimmune Diseases (15)  ·  Autoimmune Diseases of the Nervous System (15)  ·  Demyelinating Diseases (6)  ·  Demyelinating Autoimmune Diseases, CNS (5)  ·  Eye Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Chronic Disease (4)  ·  Cranial Nerve Diseases (4)  ·  Disease Attributes (4)

Interventions

Cyclophosphamide (3)  ·  Immunoglobulins, Intravenous (2)  ·  Rituximab (2)  ·  fludarabine (2)  ·  thymoglobulin (2)  ·  Antilymphocyte Serum (1)  ·  Carmustine (1)  ·  Cytarabine (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Melphalan (1)  ·  Mesna (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (3)  ·  Kyverna Therapeutics (2)  ·  Thomas Jefferson University (2)  ·  Adicet Therapeutics (1)  ·  CRISPR Therapeutics (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Hospices Civils de Lyon (1)  ·  Huashan Hospital (1)  ·  Kedrion S.p.A. (1)  ·  Mayo Clinic (1)  ·  Northwestern University (1)  ·  Tongji Hospital (1)  ·  University of South Florida (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (12)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  United Arab Emirates (1)

Top investigators

Andrew McKeon, MD (1)  ·  Dai-shi Tian, MD (1)  ·  Janus S Patel, MD (1)  ·  Laurent Servais (1)  ·  Leona Holmberg (1)  ·  Miranda Norton, PhD (1)  ·  Richard Burt, MD (1)  ·  Tuan H Vu, MD (1)

Results publications

PMID 23568718, PMID 30679041, PMID 33318163, PMID 37479377, PMID 39759515